Israel

Leading generic drug company Teva and US R&D-based major Pfizer have agreed to settle all outstanding litigation regarding three top-selling compounds. The deal refers to cancer... 2006-11-24

Israeli drugmakers Teva and Taro are to expand activities in the UK. Teva - the world's largest generics firm - has signed a deal with Schering-Plough to co-promote products for Inflammatory... 2006-11-17

Customised drugs that have been specifically tailored for individual patients could revolutionise the pharmaceutical market in the coming decades, and a number of Israeli firms are... 2006-11-09

Israeli generic giant Teva has recorded a 127% increase in profit in Q306, to US$606mn, with sales reaching US$2.29bn, up 74%. However, despite the stellar performance, BMI cautions... 2006-11-08

Investment is Israel's high tech companies will reach US$1.5bn by the end of the year, according to the Israel Venture Capital Research Centre. In Q306 Israeli firms raised US$381mn... 2006-11-02

Israeli drugmaker Teva has announced that it has received tentative approval from the US FDA for a generic version of Johnson & Johnson's schizophrenia treatment Risperdal (risperidone).... 2006-10-16

In an attempt to draw attention away from its successful but stable generic business, Israeli firm Teva Pharmaceutical Industries has showcased its pipeline of branded pharmaceuticals.... 2006-09-27

Israel represents the most advanced pharmaceuticals sector in the Middle East. At US$179, annual per capita pharmaceutical spending is the highest in the region. The market is dominated... 2006-09-26

The pharmaceutical sector was a driving force behind a the growth in Israel's s export sector in H106. According to the Manufacturers Association of Israel, foreign drug sales rose... 2006-09-14

Israeli legal experts have highlighted recent amendments to the country's 'R&D Law', which are expected to ease the transfer of technologies abroad. It is hoped that the reforms... 2006-09-06